Diagnosing and treating diseases such as cancer at an early stage can save lives. Biosignatures has developed patented machine learning technology which with the company’s powerful sample measurement system is a cost effective step forward in the discovery of new clinical diagnostics tests.
Mailing List sign-up
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.